sodium salicylate has been researched along with Idiopathic Parkinson Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nehru, B; Thakur, P | 1 |
Blandini, F; Desideri, S; Godi, L; Mancini, F; Martignoni, E; Nappi, G; Pacchetti, C | 1 |
1 trial(s) available for sodium salicylate and Idiopathic Parkinson Disease
Article | Year |
---|---|
Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA.
Topics: Antiparkinson Agents; Biomarkers; Blood Platelets; Dopamine; Female; Gentisates; Humans; Hydroxybenzoates; Hydroxyl Radical; In Vitro Techniques; Levodopa; Linear Models; Male; Middle Aged; Oxidative Stress; Parkinson Disease; Sodium Salicylate; Superoxide Dismutase; Tyrosine | 1999 |
1 other study(ies) available for sodium salicylate and Idiopathic Parkinson Disease
Article | Year |
---|---|
Modulatory effects of sodium salicylate on the factors affecting protein aggregation during rotenone induced Parkinson's disease pathology.
Topics: alpha-Synuclein; Animals; Body Weight; Glutathione; HSP70 Heat-Shock Proteins; Male; Nerve Tissue Proteins; Oxidation-Reduction; Parkinson Disease; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Rotenone; Sodium Salicylate; Ubiquitin | 2014 |